These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21842725)

  • 1. A delayed fatal metastatic Hürthle cell carcinoma.
    Noordally SO; Sohawon S; Duttmann R; Spinato L; Kleynen P; Verougstraete G
    Acta Medica (Hradec Kralove); 2011; 54(2):87-9. PubMed ID: 21842725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of malignancy rate in thyroid nodules with cytology of indeterminate follicular or indeterminate Hürthle cell neoplasm.
    Sorrenti S; Trimboli P; Catania A; Ulisse S; De Antoni E; D'Armiento M
    Thyroid; 2009 Apr; 19(4):355-60. PubMed ID: 19355826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
    Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
    Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm.
    Covach A; Patel S; Hardin H; Lloyd RV
    Endocr Pathol; 2017 Sep; 28(3):207-212. PubMed ID: 28660408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in vivo mouse model of metastatic human thyroid cancer.
    Zhang L; Gaskins K; Yu Z; Xiong Y; Merino MJ; Kebebew E
    Thyroid; 2014 Apr; 24(4):695-704. PubMed ID: 24262022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of clinical characteristics of patients with follicular thyroid carcinoma and Hürthle cell carcinoma.
    Ernaga Lorea A; Migueliz Bermejo I; Anda Apiñániz E; Pineda Arribas J; Toni García M; Martínez de Esteban JP; Insausti Serrano AM
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Mar; 65(3):136-142. PubMed ID: 29433918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metastatic Hürthle cell carcinoma of the thyroid presenting as ulcerated scrotum nodules.
    Shon W; Ferguson SB; Comfere NI
    Am J Dermatopathol; 2010 Jun; 32(4):392-4. PubMed ID: 20514683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid.
    Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI
    Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastatic Follicular Thyroid Carcinoma and the Primary Thyroid Gross Examination: Institutional Review of Cases from 1990 to 2015.
    Glomski K; Nosé V; Faquin WC; Sadow PM
    Endocr Pathol; 2017 Jun; 28(2):177-185. PubMed ID: 28444500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma.
    Mai KT; Khanna P; Yazdi HM; Perkins DG; Veinot JP; Thomas J; Lamba M; Nair BD
    Pathology; 2002 Jun; 34(3):239-44. PubMed ID: 12109784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poorly differentiated oncocytic (hürthle cell) follicular carcinoma: an institutional experience.
    Bai S; Baloch ZW; Samulski TD; Montone KT; LiVolsi VA
    Endocr Pathol; 2015 May; 26(2):164-9. PubMed ID: 25898815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic Hurthle cell tumour causing central airway obstruction.
    White SA; Goddard MJ
    J Laryngol Otol; 1993 Oct; 107(10):957-9. PubMed ID: 8263403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accumulation of p27(kip1) is associated with cyclin D3 overexpression in the oxyphilic (Hurthle cell) variant of follicular thyroid carcinoma.
    Troncone G; Iaccarino A; Russo M; Palmieri EA; Volante M; Papotti M; Viglietto G; Palombini L
    J Clin Pathol; 2007 Apr; 60(4):377-81. PubMed ID: 16798934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid.
    Máximo V; Preto A; Crespo A; Rocha AS; Machado JC; Soares P; Sobrinho-Simões M
    BMC Cancer; 2004 Mar; 4():12. PubMed ID: 15043758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follicular and Hürthle cell lesions of the thyroid: can inconclusive results be minimized?
    Sherman JF; Leiman G; Naud S; Nathan MH; Ambaye AB
    Acta Cytol; 2008; 52(6):659-64. PubMed ID: 19068668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of follicular and Hürthle cell neoplasms of the thyroid gland.
    McHenry CR; Sandoval BA
    Surg Oncol Clin N Am; 1998 Oct; 7(4):893-910. PubMed ID: 9735140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors.
    Jung CK; Kim Y; Jeon S; Jo K; Lee S; Bae JS
    Hum Pathol; 2018 Nov; 81():9-17. PubMed ID: 29723601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid Hürthle cell carcinoma metastatic to the pituitary gland.
    Fabiano AJ; Qiu J; Rigual N
    Thyroid; 2012 Apr; 22(4):442. PubMed ID: 22376169
    [No Abstract]   [Full Text] [Related]  

  • 20. [Follicular and Hurthle cell tumors of the thyroid gland. Possibilities of preoperative differential diagnosis].
    Grineva EN; Goriushkina EV; Malakhova TV; Tsoĭ UA
    Vopr Onkol; 2004; 50(1):41-5. PubMed ID: 15088519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.